As digital transformation accelerates, the cyberattack surface has expanded significantly. Cybercriminals are increasingly targeting pharmaceutical companies, driven by the high value of their intellectual property and sensitive data. The sector’s ecosystem presents numerous vulnerabilities due to a blend of legacy systems and new technologies, making data theft and system manipulation prime threats. With the shift towards continuous manufacturing, these risks have become even more critical. Successful cyberattacks impact drug formulations, intellectual property, clinical trials, company reputation, and revenue. Ultimately, it’s up to CISOs to address this convergence of challenges to protect their networks, data, and operations.
This publication:
- Examines the unique cybersecurity issues in pharmaceutical manufacturing, especially those emerging from personalized medicine, automation, and continuous manufacturing.
- Showcases real-world case studies on cyberattacks, including ransomware, OT/ICS threats, IP theft, and supply chain vulnerabilities.
- Proposes integrated protections for OT and IT systems, offering specific measures and strategies for CISOs to navigate an increasingly sophisticated threat landscape.
